JAMA Neurology Author Interviews

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

11.25.2019 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

More episodes from JAMA Neurology Author Interviews